AKT1 and neoplasm: Inhibition of AKT with LY294002 effectively inhibited the upregulation of ABCB1 by Zn2+ stimulation in tumour cells (Fig. 5k, Supplementary Fig. 5g), suggesting an AKT-dependent pathway.